Text Size

Vitamin D Pilot Study in Patients With Multiple Sclerosis

This study has been completed.
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT01257958
First received: December 8, 2010
Last updated: June 14, 2011
Last verified: December 2010
History of Changes
  Purpose

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.


Condition Intervention Phase
Relapsing Remitting Multiple Sclerosis
 Drug: 19 nor vitamin d
 Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Official Title: Vitamin D Pilot Study in Patients With Multiple Sclerosis

Resource links provided by NLM:

Drug Information available for: Vitamin D
U.S. FDA Resources

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • MRI Measure of new active lesions, observation vs. treatment

Study Start Date: February 1998
Study Completion Date: June 2000
Primary Completion Date: February 2000 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 19 nor vitamin d Drug: 19 nor vitamin d

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • relapsing remitting MS

Exclusion Criteria:

  • MRI contraindicated
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01257958

Locations
United States, Wisconsin
UW-Madison
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: John Fleming, MD, Department of Neurology - UW Madison
ClinicalTrials.gov Identifier: NCT01257958     History of Changes
Other Study ID Numbers: HSC #97-676-311
Study First Received: December 8, 2010
Last Updated: June 14, 2011
Health Authority: United States: Food and Drug Administration

Keywords provided by University of Wisconsin, Madison:
Vitamin D, 19 nor Vitamin D, Multiple Sclerosis

Additional relevant MeSH terms:
Multiple Sclerosis
Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
 Pathologic Processes
Vitamin D
Ergocalciferols
Vitamins
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on May 19, 2013